ENOCHIAN BIOSCIENCES INC.
2080 Century Park East, Suite 906
Los Angeles, CA 90067
July 16, 2020
VIA EDGAR
United States Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
Attn: Ada Sarmento
Re: ENOCHIAN BIOSCIENCES INC.
Request for Acceleration of Registration Statement on Form S-3
File No. 333-239837
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Enochian Biosciences Inc., a Delaware corporation (the “Company”), hereby requests acceleration of the effectiveness of its Registration Statement on Form S-3 (File No. 333-239837), filed with the U.S. Securities and Exchange Commission on July 16, 2019, to 4:00 P.M. ET on July 20, 2019 or as soon thereafter as practicable.
Please direct any questions or comments regarding this filing to Clayton Parker, Esq. at (305) 794-6293 of K&L Gates LLP, legal counsel to the Company.
| Sincerely, | |
| /s/ Luisa Puche | |
Luisa Puche Chief Financial Officer |
